Skip to main content
OpenTrials
Completed

NCT Number: NCT06958068

Sexual Health Integration in Treatment of Gynecological Oncology

The goal of this cross-section observational and questionary based study is to learn how geological cancer survivors perceive sexual health support given by health care professionals during diagnosis and treatment process.

The main question to be answered is:

Who, when and to what extend should discuss the sexual health issues

The participants will answer online survey questions about Sexual health issues and Sexual counselling during diagnosis, treatment and follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ovarian Cancer Adnexal Diseases Behavior Cervical Cancers Endocrine Gland Neoplasms Endocrine System Diseases Endometrial Cancer Endometrial Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Gonadal Disorders Neoplasms Neoplasms by Site Ovarian Diseases Ovarian Neoplasms Sexual Behavior Sexual Counselling Sexual Health Quality of Life Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Cervical Neoplasms Uterine Diseases Uterine Neoplasms Vaginal Cancers Vaginal Diseases Vaginal Neoplasms

Age range

18 year–85 year

Sex eligibility

Female

Study type

Observational

Primary location

Department of Gynaecology, Obstetrics and Gynaecological Oncology, University Clinical Centre, Medical University of Silesia

Katowice, Silesian Voivodeship, 40-752, Poland

About this study

The main aim of the study is to verify who, from medical specialist, should discuss the sexual health issues in gynecological cancer survivors, when that discussion should take places and to what exited all sexual issues should be discusses.

The secondary end points are:

  • to establish factors affecting returning to sexual activities defined as any type of physical contact with a partner engaging sexual organs as well as mutual and solo masturbation.
  • to verified if gender of counselling specialist is important to patients.

The study is a cross-section observation one. It is based on a survey containing questions regarding basic socioeconomical factors, treatment history, reproductive history, and those concerning the opinion who, when, to what extend and how should ask about sexual issues during therapy modalities planning, treatment and follow-up.

Women after completing a treatment irrespectively of its type (surgery, radiation, chemotherapy, immune check point inhibitors) will be eligible for the study. Those who are no more sexually active and currently have no sexual partner will also be included.

After collecting the date three main analysis will be conducted to answer the study questions.

The results will be used as a basic for further work on recommendation on sexual health counselling in gynecological malignancies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosed with gynecological malignancies except breast cancer
  • completion of treatment irrespectively of its type (surgery, CTH, RTH, immunotherapy)
  • ECOG≤2

Exclusion criteria

  • diagnosed with breast cancer
  • currently being treated for gynecological or other malignancies
  • ECOG >2
  • not being able to have any type of sexual activity due to physical limitations or comorbidities

Treatment and study plan

Primary outcomes

  1. Who should counsel patients with gynecological malignancies

    Time frame: At least 8 weeks post treatment completion

    A set of questions were asked to verify the hypothesis that specialist in gynecological oncology should inform about sexual issues during the treatment ant after its completion. Timing, frequency of counselling and patients' preferences for sexual information sources were established.

Secondary outcomes

  1. Gender of gynecological oncologist counselling the patient

    Time frame: At least 8 weeks post treatment completion

    A set of questions were ask to verify the hypothesis that in case of cancer choosing the specialist in gynecological oncology in not gender-based but knowledge and skills-based.

  2. Returning to sexual activity defining as any sexual contact with a partner or solo masturbation

    Time frame: At least 8 weeks post treatment completion

    A set of question were asked to verify factors that might influence returning to sexual activity after treatment completion

Sponsors and collaborators

Lead sponsor

Medical University of Silesia

Other

Registry information

Official study title

Integrating Mandatory Sexual Health Counseling in Gynaecological Oncology: A Paradigm Shift From Diagnosis to Survivorship.

Acronym: SHIFT-GO

Important dates

Study start
2022
Primary completion
2024
Study completion
2025
First posted
May 6, 2025
Registry last updated
Aug 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.